Literature DB >> 12665176

Application of a depression management office system in community practice: a demonstration.

Allen J Dietrich1, Thomas E Oxman, Mary R Burns, Charlotte W Winchell, Tanya Chin.   

Abstract

BACKGROUND: Recent studies provide new insights about strategies that improve depression outcomes. We explored the feasibility of implementing these strategies in community practices.
METHODS: Clinicians followed an office system approach to management of depression. There were no controls. The office system was based on established routines performed by a primary care clinician working in a prepared practice, a telephone care manager, and a collaborating psychiatrist, all using a common severity monitoring tool. Five practices with 18 clinicians participated. Sixty-six adult patients had depression diagnosed, and 60 (91%) received care according to the model through 8 weeks of follow-up visits. Depression outcomes were assessed using PHQ-9.
RESULTS: At baseline, 48 (80%) patients met criteria for major depressive disorder, chronic depression, or both, while others had less severe symptoms. Of 32 patients with moderately severe or severe depression, the 8-week follow-up severity score decreased by > or = 50% for 23 (70%). Of patient barriers to adherence, ambivalence about treatment and medication side effects were most common. Most patients received three care manager telephone calls requiring 6 to 10 minutes each.
CONCLUSION: Application of the office system was feasible in this demonstration project. If results are confirmed in further studies, this approach will be appropriate for widespread application.

Entities:  

Mesh:

Year:  2003        PMID: 12665176     DOI: 10.3122/jabfm.16.2.107

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  9 in total

1.  Correlation between mental health co-morbidity screening scores and clinical response in collaborative care treatment for depression.

Authors:  Kurt B Angstman; Ramona S Dejesus; James E Rohrer
Journal:  Ment Health Fam Med       Date:  2010-09

2.  Literacy education as treatment for depression in patients with limited literacy and depression: a randomized controlled trial.

Authors:  Barry D Weiss; Laurie Francis; Janet H Senf; Kim Heist; Rie Hargraves
Journal:  J Gen Intern Med       Date:  2006-08       Impact factor: 5.128

3.  Stepped care treatment of postpartum depression: impact on treatment, health, and work outcomes.

Authors:  Dwenda Gjerdingen; Scott Crow; Patricia McGovern; Michael Miner; Bruce Center
Journal:  J Am Board Fam Med       Date:  2009 Sep-Oct       Impact factor: 2.657

4.  Validity/reliability of PHQ-9 and PHQ-2 depression scales among adults living with HIV/AIDS in western Kenya.

Authors:  Patrick O Monahan; Enbal Shacham; Michael Reece; Kurt Kroenke; Willis Owino Ong'or; Otieno Omollo; Violet Naanyu Yebei; Claris Ojwang
Journal:  J Gen Intern Med       Date:  2008-11-20       Impact factor: 5.128

5.  Diseases of poverty and lifestyle, well-being and human development.

Authors:  Ajai R Singh; Shakuntala A Singh
Journal:  Mens Sana Monogr       Date:  2008-01

6.  Poor response to treatment: beyond medication.

Authors:  César Carvajal
Journal:  Dialogues Clin Neurosci       Date:  2004-03       Impact factor: 5.986

7.  Factors affecting therapeutic compliance: A review from the patient's perspective.

Authors:  Jing Jin; Grant Edward Sklar; Vernon Min Sen Oh; Shu Chuen Li
Journal:  Ther Clin Risk Manag       Date:  2008-02       Impact factor: 2.423

8.  Improving mental health outcomes: achieving equity through quality improvement.

Authors:  Alan J Poots; Stuart A Green; Emmi Honeybourne; John Green; Thomas Woodcock; Ruth Barnes; Derek Bell
Journal:  Int J Qual Health Care       Date:  2014-02-11       Impact factor: 2.038

9.  Anxiety and depression among medical doctors in Catalonia, Italy, and the UK during the COVID-19 pandemic.

Authors:  Climent Quintana-Domeque; Ines Lee; Anwen Zhang; Eugenio Proto; Michele Battisti; Antonia Ho
Journal:  PLoS One       Date:  2021-11-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.